To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.
Clinical trial NCT05673694 · UNKNOWN
Trial details
- NCT number
- NCT05673694
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2025-11-07
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.